U.S. markets closed

Athenex, Inc. (ATNX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
3.77000.0000 (0.00%)
At close: 4:00PM EDT
Sign in to post a message.
  • T
    Tom
    I am shocked how this company is undervalued. Unbelievable! They have an excellent drug pipeline (already approved and expanding), scientific articles published in high-impact journals. You can check in here by typing "Athenex": https://clinicaltrials.gov/ct2/search/advanced?cond=&term=&cntry=&state=&city=&dist=

    They almost built a pharma plant. The min price for this is $20-$30
    Bullish
  • C
    Carl
    From clinical trial enrollment Q1 2022 to FDA submission: 18 months plus FDA review 6 months = 24 months. It could be a good idea to set up (now) a Compassionate Use Program and gather data through that as well. In 24 months: Class Action is dismissed, the insurance settles with some investors and the skies clear up. In the interval: new technologies come forward, the pipeline matures and some sales maintain the company afloat. But the question is: How much cash will it take to conduct this 2 year-journey? If this path is clear until then, with a decent amount of PR (around scientific meetings), we should be rewarded.
  • C
    Christopher
    Well guys...worth buying yet or is it going to drop further?? not sure on cash on hand or up coming news flow but share price under $4 is tempting on a historical chart basis
    Neutral
  • T
    Tony23
    Earnings call August 5 should tell us a lot - and be the pivot point for a slow turnaround.
  • E
    Er. Pradip Chitrakar
    there is probably one hedge fund manager bringing the price down all day and gobbling up shares at end of day. there is always huge buy at 4:00pm here.
  • T
    The Real Blake
    I assume this thing will break out big at some point. But in the meantime, it's a painfully slow slog.
  • D
    Damond
    The Form 8k announcement to reserve 5million shares for insider compensation should reduce the Float enough to let this climb a bit higher.
  • T
    Tony23
    During the May CC and financial discussion, the Company said it had enough cash/equivalent to get to the 2nd half of 2022 ... does anyone know whether this estimate INCLUDED the $70mm payment for KUUR? (and where is that at this point, anyway?). Sales estimate given at that call was for a flat 2021. Not sure how much growth opportunity there is for 501 group products ... but they must have something in mind for this huge new facility? Everything else seems in early development stages and a long way and a lot of $$ from commercialization. Is a BO a possibility for ATNX?
  • I
    I
    Back on the rise
    Bullish
  • J
    John
    I don't get it. should be up on this recent news
  • K
    Ken
    This would be a great stock for the Reddit WallStreetBets folks. Company trying to get pharmaceutical products to market that saves lives and it has a huge Short position.
  • C
    Christopher
    bought some avg 3.95 so happy enough with that as last time I bought I managed to have a sell order at 5.63 and it triggered
  • T
    Tony23
    Having trouble seeing the silver lining here at this point.
  • w
    well
    Week after week no news.
    Neutral
  • D
    Damond
    Isn't the Russell rebalance happening tomorrow? If so, tomorrow could be a very interesting day.
    Bullish
  • T
    Tony23
    What's the next positive catalyst on deck? Plant opening? Mtg with FDA? Paint drying?
  • T
    Tony23
    Over a million traded AH seems oddly high given the day's volume?
  • o
    oksundang
    we got 1bad news today but we also should notice Orphan Drug Designation for sarcoma that is not bad news
    Bullish
  • A
    Ahmed
    vanguard added more than 3M shares in both of their mutual funds on 1/June/2021

    VTSMX - Vanguard Total Stock Market Index Fund Investor Shares
    VEXMX - Vanguard Extended Market Index Fund Investor Shares